See All Slides - tctmd.com

Slides

Presentation TCT 2014

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Presenter: Kazuyuki Yahagi

September 16, 2014

Presentation TCT 2014

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Presenter: Ronald Binder

September 16, 2014

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Presenter: Ming Kai Lam

September 16, 2014

Presentation TCT 2014

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Presenter: Yeo-Jeong Song

September 16, 2014

Presentation TCT 2014

Multi-Slice Computed Tomography Procedural Planning For Transcatheter Mitral Annuloplasty

Presenter: Jovana Pavicevic

September 16, 2014

Presentation TCT 2014

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Very Low Intravenous Contrast Dose (20cc) Protocol for Computed Tomography Angiography (CTA) Providing Comprehensive Cardiac and Vascular Assessment for Transcatheter Aortic Val___

Presenter: Todd Pulerwitz

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Presenter: Fausto Feres

September 16, 2014

Presentation TCT 2014

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Presenter: Ferdinando Varbella

September 16, 2014

Advertisement

Slides

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Multi-Slice Computed Tomography Procedural Planning For Transcatheter Mitral Annuloplasty

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Very Low Intravenous Contrast Dose (20cc) Protocol for Computed Tomography Angiography (CTA) Providing Comprehensive Cardiac and Vascular Assessment for Transcatheter Aortic Val___

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content